Abstract:Abstract Background Post-acute sequelae of COVID-19 [PASC] is thought to occur in 10% of all COVID infections and has previously been associated with autonomic dysfunction including postural orthostatic tachycardia syndrome [POTS].[1,2] Purpose To assess prevalence of autonomic disorders in those with PASC. Methods Consecutive patients reporting unexplained symptoms persisting for ≥3 months after SARS-CoV-2 infection were recruited through social media platforms. Beat to beat plethysmography was used to determine autonomic haemodynamic response to 10-minute active stand test, Valsalva maneuverer and deep breathing. International criteria were used to diagnose POTS, initial orthostatic hypotension (IOH), and classical orthostatic hypotension (COH). Validated patient reported outcome measures were used to determine symptom severity and health related quality of life (HrQoL) including, composite autonomic symptom score [COMPASS-31], Euroquol 5-Dimension [EQ-5D] and fatigue severity score (FSS). Results Institutional ethics was granted from our university. A total of 150 PASC participants (79% female, 93% Caucasian) with a mean age of 40.7 ± 11.5 years and BMI 25.8 ± 6.7 were prospectively consented and enrolled. In total 86% were vaccinated with at least 2 vaccines at the time of acute SARS-CoV-2 infection. The mean time to onset of PASC symptoms after acute infection was 18.3 ± 35.3 days and duration of symptoms at time of testing was 306.9 ± 188.1 days. In total 75% of participants met the criteria for an autonomic disorder with the most common diagnoses being POTS (55%), initial orthostatic hypotension (38%), and classic orthostatic hypotension (5%) respectively. Valsalva ratio was within normal limits for the majority (90%) of participants however it was statistically higher in those with POTS compared to those without (1.9±.6 versus 1.7±.8: p=.014). Total composite autonomic symptoms were more severe in women than men (42.6±13.1 vs. 35.4±19.9; p = .018) and those with a COMPASS-31 score >40 (49%) had worse fatigue severity (57.9±6.9 vs. 50.3±14.3: p<.001) and poorer EQ-5D utility health scores (0.611±0.247 vs 0.701±0.237: p =.008) on a scale from 0-1 where ‘1’ = ‘full health’. The mean FSS score was 53.9±11.8 out of a maximum score of 63 and fatigue was universally problematic with 92% experiencing FSS score >36. Participants reported only being a mean of 40.5%±21.2% of their previous health status and the mean self-reported ‘health today’ [100 = ‘full health’] was 40.5 ± 14.2. A significant 91.3% reported missing work due to symptoms in the last month and 50.3% had been unable to return to work due to PASC symptoms. Conclusion Autonomic disorders are prevalent in PASC and greatly impact on working capacity and health related quality of life. We call for routine autonomic testing in PASC and further research to explore efficacy of autonomic treatment modalities in this cohort.

Pelvic autonomic dysfunction is common in patients with pure autonomic failure

Cardiovascular Autonomic Dysfunction is Associated with Executive Dysfunction and Poorer Quality of Life in Progressive Supranuclear Palsy-Richardson’s Syndrome

Autonomic Function and Motor Subtypes in Parkinson’s Disease: a Multicentre Cross-Sectional Study

Neurodegenerative disorders affecting the autonomic nervous system: Pure autonomic failure and multiple system atrophy

Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment

Natural history of pure autonomic failure: A United States prospective cohort

Primary autonomic failure: a complex case of orthostatic hypotension in a hypertensive elderly patient

Hemodynamic recognition of pure autonomic failure: A case report

Autonomic dysfunction is prevalent in PASC of Covid-19 [PASC]

Abnormal dopamine transporter imaging in pure autonomic failure: a potential biomarker of central nervous system involvement

Autonomic symptoms and associated factors in patients with chronic heart failure

Autonomic Dysfunction in Parkinson’s Disease: Implications for Pathophysiology, Diagnosis, and Treatment

Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy

The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study

Assessment of Autonomic Dysfunction in Patients with Parkinson's Disease

When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?

Chronic idiopathic urinary retention: Comorbidity and outcome in 102 individuals

Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease

High Prevalence of Psychological Comorbidities and Functional Neurological Symptoms in Women With Urinary Retention

Autonomic impairment in primary lateral sclerosis

Phenoconversion in pure autonomic failure: a multicentre prospective longitudinal cohort study